Cerus (CERS) Competitors $1.31 0.00 (0.00%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$1.30 -0.01 (-0.38%) As of 08/29/2025 06:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CERS vs. OSUR, UTMD, ANIK, WST, COO, ALGN, MMSI, ICUI, XRAY, and HAEShould you be buying Cerus stock or one of its competitors? The main competitors of Cerus include OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), and Haemonetics (HAE). These companies are all part of the "health care supplies" industry. Cerus vs. Its Competitors OraSure Technologies Utah Medical Products Anika Therapeutics West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems ICU Medical DENTSPLY SIRONA Haemonetics Cerus (NASDAQ:CERS) and OraSure Technologies (NASDAQ:OSUR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, earnings and risk. Is CERS or OSUR more profitable? Cerus has a net margin of -9.81% compared to OraSure Technologies' net margin of -36.84%. OraSure Technologies' return on equity of -10.81% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets Cerus-9.81% -33.77% -9.32% OraSure Technologies -36.84%-10.81%-9.44% Which has more risk & volatility, CERS or OSUR? Cerus has a beta of 1.63, suggesting that its share price is 63% more volatile than the S&P 500. Comparatively, OraSure Technologies has a beta of 0.44, suggesting that its share price is 56% less volatile than the S&P 500. Does the media refer more to CERS or OSUR? In the previous week, OraSure Technologies had 2 more articles in the media than Cerus. MarketBeat recorded 3 mentions for OraSure Technologies and 1 mentions for Cerus. Cerus' average media sentiment score of 1.20 beat OraSure Technologies' score of 0.43 indicating that Cerus is being referred to more favorably in the media. Company Overall Sentiment Cerus Positive OraSure Technologies Neutral Which has better earnings & valuation, CERS or OSUR? OraSure Technologies has higher revenue and earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCerus$180.27M1.39-$20.92M-$0.10-13.10OraSure Technologies$185.83M1.30-$19.50M-$0.67-4.94 Do institutionals and insiders have more ownership in CERS or OSUR? 78.4% of Cerus shares are owned by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are owned by institutional investors. 3.4% of Cerus shares are owned by company insiders. Comparatively, 3.9% of OraSure Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts prefer CERS or OSUR? Cerus presently has a consensus target price of $3.50, suggesting a potential upside of 167.18%. OraSure Technologies has a consensus target price of $3.00, suggesting a potential downside of 9.37%. Given Cerus' stronger consensus rating and higher probable upside, equities analysts plainly believe Cerus is more favorable than OraSure Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00OraSure Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryCerus beats OraSure Technologies on 9 of the 16 factors compared between the two stocks. Get Cerus News Delivered to You Automatically Sign up to receive the latest news and ratings for CERS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CERS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CERS vs. The Competition Export to ExcelMetricCerusMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$251.12M$11.00B$5.71B$9.76BDividend YieldN/A1.84%6.66%4.48%P/E Ratio-13.1022.1883.1026.57Price / Sales1.3931.90544.91112.35Price / CashN/A25.1325.6628.92Price / Book4.233.6011.766.08Net Income-$20.92M$212.34M$3.27B$265.84M7 Day Performance2.34%1.03%1.13%0.36%1 Month Performance3.15%16.24%8.30%5.58%1 Year Performance-42.04%-7.76%62.26%19.67% Cerus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CERSCerus2.8775 of 5 stars$1.31flat$3.50+167.2%-42.0%$251.12M$180.27M-13.10290OSUROraSure Technologies1.8875 of 5 stars$3.14+4.7%$3.00-4.5%-26.1%$219.41M$138.53M-4.69840High Trading VolumeUTMDUtah Medical Products2.6445 of 5 stars$60.34-1.0%N/A-8.5%$195.37M$40.90M16.13180ANIKAnika Therapeutics4.2875 of 5 stars$9.13-5.4%$18.00+97.2%-63.5%$139.13M$119.91M-2.20300WSTWest Pharmaceutical Services4.873 of 5 stars$246.98-0.4%$320.71+29.9%-21.2%$17.82B$2.89B36.9710,600Positive NewsCOOCooper Companies4.281 of 5 stars$73.48-2.3%$96.73+31.6%-36.3%$15.04B$3.90B35.6716,000Earnings ReportALGNAlign Technology4.9314 of 5 stars$144.96-3.1%$215.00+48.3%-40.2%$10.84B$4.00B24.4520,945Positive NewsMMSIMerit Medical Systems4.7248 of 5 stars$88.16-1.4%$107.00+21.4%-6.4%$5.30B$1.36B44.757,400Positive NewsICUIICU Medical4.6037 of 5 stars$125.81-1.8%$179.00+42.3%-22.8%$3.16B$2.38B-82.7715,000Positive NewsXRAYDENTSPLY SIRONA4.987 of 5 stars$14.40-1.8%$18.64+29.4%-43.5%$2.92B$3.79B-3.0414,000Analyst RevisionHAEHaemonetics4.9033 of 5 stars$55.30-1.9%$85.18+54.0%-27.7%$2.72B$1.36B16.913,023Positive News Related Companies and Tools Related Companies OSUR Competitors UTMD Competitors ANIK Competitors WST Competitors COO Competitors ALGN Competitors MMSI Competitors ICUI Competitors XRAY Competitors HAE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CERS) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersNew Banking Law #1582 Could Unlock $21 Trillion for AmericansDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerus Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CERS Stock Alerts